International Journal of Cancer · 1989 · 337 citations · 19 references
MedicineMolecular BiologyPathologyCellular PathologyMolecular OncologyNeoplasiaEpithelial TumorsImmunohistochemistryMammary TumorsTumor AntigensTumor ImmunopathologyTumor-associated AntigensAberrant Glycosylation In CancerCancer-associated MucinsImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingMucin AntigensMucin BiologyMucin Glycoproteins
The monoclonal antibody (MAb) SM-3, which was raised to chemically deglycosylated milk mucin, reacts with an epitope present on the core protein of this mucin which we have referred to as PEM (polymorphic epithelial mucin). Although this mucin is abundantly expressed by both the lactating breast and breast carcinomas, the antibody SM-3 shows very little or no reactivity on the former but does react with 92% of breast carcinomas. Furthermore, SM-3 stains primary carcinomas of the lung, colon and ovary, but on the corresponding normal tissue the epitope is expressed at a much reduced level or not at all. These results indicate that an epitope masked in the normal mucin is exposed in the mucin produced by tumour cells, perhaps due to aberrant glycosylation. An extensive immunohistochemical study of other normal tissues reveals that the majority show only weak focal staining with SM-3 or none at all, the distal tubules and collecting ducts of the kidney, and sebaceous glands being the only normal tissues studied to show homogeneously positive staining.
19
Joyce Taylor‐Papadimitriou, Jerry A. Peterson, J. Arklie et al. · International Journal of Cancer · 1981 · 604 citations
Sandra Gendler, Joyce Taylor‐Papadimitriou, Trevor Duhig et al. · Journal of Biological Chemistry · 1988 · 574 citations · Full text
Joy Burchell, H. Durbin, Joyce Taylor‐Papadimitriou · The Journal of Immunology · 1983 · 333 citations · Full text